Value Sense
HUM
Humana Inc. (HUM)
Last Price$261.5(3.3%)
Market Cap$31.5B
Intrinsic value score
6/10
Good
Intrinsic value
$797.8
DCF value - $1,197.5 Relative value - $398.1
Undervalued
205.0%
LTM P/E
26.1x
Peer set median 15.2x
Discount rate
5.7%
HUM
is 205.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

HUM Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 HUM Relative Value is $400.4, which is undervalued by 53.1%, compared to current share price of $261.5.
DCF Value vs Current Share Price
As of Mar 03, 2025 HUM DCF Value is $1,195.0, which is undervalued by 356.9%, compared to current share price of $261.5.
Methodology
Price per share, $
HUM
Intrinsic value$797.8
Undervalued by205.0%
Current share price
261.5
Relative value
400.4
DCF value
1,195.0

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

HUM Historical Intrinsic Value

Crunching data... Almost there!

HUM vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Humana Inc. logo
Humana Inc.HUM
205.0%
10.7%
(50.1%)
1.0%
Median Peer Set
7.2%
(2.4%)
1.6%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(47.0%)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(45.3%)
(41.5%)
(31.3%)
(10.5%)
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
37.0%
19.3%
9.2%
2.9%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
57.0%
56.5%
N/A
0.3%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
124.2%
8.9%
(35.7%)
3.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
153.3%
3.2%
(0.0%)
3.4%
Cigna Corporation logo
Cigna CorporationCI
202.7%
8.4%
(18.9%)
2.6%
CVS Health Corporation logo
CVS Health CorporationCVS
220.8%
4.2%
(43.6%)
1.2%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
463.3%
(51.9%)
86.2%
(103.4%)
Centene Corporation logo
Centene CorporationCNC
2,301.3%
5.9%
27.4%
2.0%

Explore more intrinsic value tools hub for HUM

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is Humana Inc. intrinsic value?

As of Mar 03, 2025, Humana Inc. Intrinsic Value is $797.8. This suggests it may be undervalued by 205.0% compared to its current price of around $261.5.

What is Humana Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Humana Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $1,195.0. This suggests it may be overvalued by 356.9% to its current price of around $261.5, using a discount rate of 5.7% and terminal growth rate of 3.0%.

Is Humana Inc. overvalued or undervalued?

Humana Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $797.8, compared to a market price of around $261.5. This suggests a potential undervaluation of 205.0%.